Abstract
Background Despite scale-up of antiretroviral therapy (ART), children living with HIV (CLHIV) and children who are HIV-exposed-but-uninfected (CHEU) are at an increased risk of poor growth outcomes compared to children HIV-unexposed-and-uninfected (CHUU). Few studies quantify the magnitude of growth deficits extending into school age in sub-Saharan Africa (SSA). This study examined the impact of perinatal HIV exposure and infection on the growth trajectory of school-aged children in Nigeria.
Methods Within a prospective cohort, 569 children aged 3-11 years were recruited from pediatric clinics in Nigeria and matched by age and sex based on their exposure or infection status. School-aged children were observed across three time-points at 6-month intervals, during which anthropometric measures, CD4 count, and maternal factors were collected. Z-scores for height-for-age (HAZ), weight-for-age (WAZ), and body-mass-index-for-age (BAZ) were calculated using WHO standards. Longitudinal linear regression analyses using generalized estimating equations (GEE), adjusted for maternal and child covariates, were conducted to compare growth outcomes across groups.
Results Growth Z-scores declined until approximately age 8, after which they gradually increased. Across all visits, CLHIV consistently and independently demonstrated lower Z-scores (WAZ (β = -1.04, p <0.001); HAZ (β = -0.67, p <0.001)), followed by CHEU with intermediate but significant impairments (WAZ (β = -0.35, p <0.01); HAZ (β = -0.38, p <0.01)) compared to CHUU.
Conclusion Stunting remains unacceptably high in CLHIV and CHEU in SSA. The findings suggest a need for immediate paradigm shifts to address persistent growth deficits despite ART and beyond infancy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partly supported by a grant from the National Institutes of Health (NIDCR R01DE028154 and R01DE032216). The funder had no role in the study design, collection, analysis, interpretation of the data, or manuscript writing.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional Review Board of the University of Benin Teaching Hospital, the Institutional Review Board of the University of Maryland, Baltimore, and the Institutional Review Board of Rutgers State University of New Jersey gave ethical approval for this work. Written informed consent was obtained from parents or guardians of all participants prior to enrollment.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that supportt the findings of this study are available from the corresponding author upon resonable request, subject to institutional review and ethical approval to ensure participant confidentiality.
Abbreviations
- ART
- Antiretroviral therapy
- DOMHaIN
- Dental caries and its association with oral microbiomes and HIV in young children—Nigeria
- HIV
- Human immunodeficiency virus
- CLHIV
- Children Living with HIV
- CHEU
- Children HIV-exposed-but-uninfected
- CHUU
- Children HIV-unexposed-uninfected
- SSA
- sub-Saharan Africa
